Egfr Mutation Analysis

Summary

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses Dr. Geoffrey Oxnard describes a study that aims to identify non-smoking lung cancer patients who have a rare Nathan Pennell, MD, PhD, associate professor of Medicine at Cleveland Clinic, discusses the importance of Learn more about lung cancer at YouAndLungCancer.org Lung cancer expert Dr. Naomi Fujioka of the University of ... ... MD; Alexander Drilon, MD; and Jared Weiss, MD, provide insight on which At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Martin Reck, MD, ... Lynette M. Sholl, MD, and Geoffrey R. Oxnard, MD, discuss Panelists Mark Socinski, MD, and Edward S. Kim, MD, discuss the rationale for Samreen Ahmed, FRCP, MD, MBBS, MSc, University Hospitals of Leicester NHS Trust, Leicester, UK, discusses the Phase III ... Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, provides an overview on a ... EGFR, precision medicine, biomarker Hazel O'Sullivan, MBBS, The Royal Marsden NHS Foundation Trust, London, UK, provides an overview of an investigation into ...